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I.  PRD RISK TITLE: RISK OF CARDIAC RHYTHM PROBLEMS 
Description: Heart rhythm disturbances have been observed in some astronauts and 
cosmonauts during spaceflight, but it is not clear whether these arrhythmias result from 
pre-existing conditions or effects of spaceflight. It is hoped that advancements in 
screening for cardiovascular disease have greatly mitigated this risk. Other heart rhythm 
problems, such as atrial fibrillation, can develop in crewmembers with normal aging and 
require periodic screening. There have been suggestions that some spaceflight-related 
factors may contribute to or hasten the development of these arrhythmias.    
 
II.  EXECUTIVE SUMMARY 
NASA has concerns regarding the incidence and clinical significance of cardiac 
arrhythmias that could occur during long-term exposure to the spaceflight environment, 
such as on the International Space Station (ISS) or during a prolonged (e.g., up to 3 
years) sojourn to Mars or on the Moon. There have been some anecdotal reports and a 
few documented cases of cardiac arrhythmias in space, including one documented 
episode of non-sustained ventricular tachycardia. The potential catastrophic nature of a 
sudden cardiac death in the remote space environment has led to concerns from the early 
days of the space program that spaceflight might be arrhythmogenic. Indeed, there are 
known and well-defined changes in the cardiovascular system with spaceflight:  a) 
plasma volume is reduced, b) left ventricular mass is decreased, and c) the autonomic 
nervous system adapts to the weightless environment. Combined, these physiologic 
adaptations suggest that changes in cardiac structure and neuro-humoral environment 
during spaceflight could alter electrical conduction, although the evidence supporting this 
contention consists mostly of minor changes in QT interval (the time between the start of 
the Q wave and the end of the T wave on an electrocardiogram tracing) in a small number 
of astronauts after long-duration spaceflight. Concurrent with efforts by NASA Medical 
Operations to refine and improve screening techniques relevant to arrhythmias and 
cardiovascular disease, as NASA enters the era of exploration-class missions it will be 
critical to determine with the highest degree of certainty whether spaceflight by itself 
alters cardiac structure and function sufficiently to increase the risk of arrhythmias.  
 
III. INTRODUCTION 
Some have postulated that the incidence and severity of cardiac arrhythmias would 
increase as the number and duration of spaceflights increased (Leguay and Seigneuric 
1981; Atkov and Bednenko 1992). At present, however, there is little evidence 
suggesting that cardiovascular adaptation to weightlessness or other spaceflight factors 
increases astronauts’ susceptibility to life threatening arrhythmias. From a clinical 
perspective, according to the “biological model” of sudden cardiac death (Myerburg et al. 
1989), both the substrate and the trigger for arrhythmias should be considered to 
determine whether long-term spaceflight could lead to an increased risk of sudden death. 
In this model, structural abnormalities interact with functional alterations, such as 
electrolyte disturbances,or neuro-humoral modulation, to create an environment in which 
arrhythmias can be initiated and/or sustained. In patients with coronary artery disease, the 
substrate is clear: a myocardial infarction (MI) and/or scar leading to focal areas of 
slowed conduction, a necessary condition for reentry of the electrical impulse. For 
patients with apparently normal ventricular function, the potential substrate is less 
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certain. In fact, reentry often is not the mechanism of arrhythmia development in these 
clinical cases: the arrhythmias may be caused by delayed after-depolarizations, and the 
triggered activity may be mediated via catecholamines (Lerman et al. 1996). The 
published report of non-sustained ventricular tachycardia during prolonged spaceflight 
(Fritsch-Yelle et al. 1998) supports this hypothesis, in that initiation of tachycardia by a 
late diastolic premature ventricular contraction (PVC) is more consistent with triggered 
activity than it is with reentry. 
There are no definitive data showing that spaceflight is associated with increased 
frequency or complexity of cardiac arrhythmias, but observational data have been 
documented that by themselves might suggest that arrhythmias are more prevalent during 
long flights. There were few reported arrhythmias during early NASA spaceflight 
programs (Berry 1968; Charles et al. 1996), with the exception of a 22-beat nodal 
bigeminal rhythm, which was followed by atrial premature beats, during a lunar EVA 
(Rossum et al. 1997).  Holter monitoring performed during 4-16 day Space Shuttle 
missions revealed the frequencies of arrhythmias during either intravehicular or 
extravehicular operations (EVA) were virtually the same as frequencies measured before 
flight (Fritsch-Yelle et al. 1996a; Rossum et al. 1997). Indeed, in these studies, the 
frequency of arrhythmias may actually have been reduced in flight, although the 
investigators did not quantify the day-to-day variability of these arrhythmias which is 
known to be quite wide.  However, during Skylab missions (28-84 days), all 9 
crewmembers exhibited some form of rhythm disturbance. Most of these rhythm 
disturbances consisted of single PVCs that were clinically insignificant. Additionally, one 
crewmember experienced a 5-beat run of ventricular tachycardia during a lower body 
negative pressure (LBNP) protocol, and another crewmember had periods of “wandering 
supraventricular pacemaker” during rest and following exercise. Also, PVCs were 
detected aboard the Mir space station that were not present before flight (Goldberger et 
al. 1994), and a 14-beat run of ventricular tachycardia was documented (Fritsch-Yelle et 
al. 1998) (Figure 1). 
 
Figure 1.  A non-sustained tachycardia recorded in a Mir crewmember (Fritsch-Yelle et 
al. 1998). 
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The potential for an increased incidence of arrhythmias during spaceflight might be 
inferred from crewmember-specific factors (e.g., age, sex) and spaceflight-related 
adaptations (e.g., fluid shifts, electrolyte disturbances).  For example, after long-duration 
missions corrected QT intervals (QTc), a marker of ventricular repolarization, are slightly 
prolonged in crewmembers who did not have prolonged QTc intervals after their short-
duration  Space Shuttle flights (D’Aunno et al. 2003).  Unfortunately, Holter monitoring 
was not performed during these spaceflights; thus, it is not known whether this 
prolongation was associated with any arrhythmias.  Additionally, several investigators 
have reported that astronauts have decreased left ventricular mass after spaceflight 
(Perhonen et al. 2001; Summers et al. 2007).  Additional potential contributors to this risk 
are discussed in detail below. 
All of these findings raise the concern that cardiac rhythm disturbances may become 
an issue during the long in-flight tours of duty planned on ISS and future exploration 
missions; several 1-year ISS missions are being planned, and Mars missions will last 
approximately 3 years. The degree to which spaceflight and its many variables can be 
considered arrhythmogenic is not clear, but a serious cardiac rhythm disturbance could 
have significant impacts on both the spaceflight mission and the long-term health of 
astronauts and cosmonauts. 
 
IV.  EVIDENCE 
A.  Spaceflight Evidence 
Early space program objectives were directed towards launching humans successfully 
into space and safely returning them home, while gaining an appreciation of the 
physiological responses to spaceflight (Berry 1968). The human body is evolutionarily 
adapted to survive in a 1 g gravitational environment (Romero et al. 2015); thus, 
physiological functions in weightlessness could not be predicted with certainty. To 
monitor cardiovascular health and function, electrocardiogram (ECG) monitoring of 
astronauts and cosmonauts was routine practice in early spaceflight missions, but became 
less frequent as experience was gained with the novel environment of weightlessness and 
no emergent cardiovascular events were observed (Charles et al. 1996). In later flights, 
continuous ECG recordings were performed as part of a science experiment, during 
mission events that might be particularly stressful to the cardiovascular system (e.g., 
launch, landing, extravehicular activities [EVA]) or during the performance of potentially 
provocative countermeasures (e.g., exercise, LBNP). Thus, evidence of arrhythmias 
during spaceflight largely has been anecdotal or observational, although a few systematic 
studies have been conducted. As a result, ascribing the appearance of arrhythmias during 
spaceflight to the spaceflight exposure has been difficult. Table 1 includes an overall 
summary of currently published reports (5).   
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Table 1.  Summary of reported arrhythmias by flight phase. Adapted from Charles et al. 
(1996) with supplemental information from others (Berry 1968; Fritsch-Yelle et al. 1998; 
Gontcharov et al. 2005; Grigoriev et al. 2009). Results are from published reports.  PAC: 
premature atrial contraction.  PVC: premature ventricular contraction. 
Program During Launch During Flight During EVA During 
Reentry or 
Landing 
After Flight 
Mercury Rare PACs, 
PVCs during 
pre-launch 
activities 
More pronounced 
sinus dysrhythmia. 
One PAC, one PVC, 
one fusion beat 
No EVAs 
performed 
  
Gemini  Rare PACs, PVCs 
(Berry 1968) 
   
Apollo  On Lunar surface: 
PVCs, PACs during 
normal flight, sleep 
and awakening, and 
after return to Lunar 
surface 
Lunar surface 
EVA: atrial 
bigeminal 
rhythm with 
extreme fatigue 
  
Skylab  PVCs during normal 
flight and exercise; 
AV block during 
LBNP recovery; 
ectopic beats during 
LBNP; AV 
junctional rhythm at 
rest and during 
LBNP; ST segment 
and T-wave changes 
during maximum 
stress; ventricular 
couplet, 3-beat 
ventricular 
tachycardia during 
exercise 
  Ventricular 
tachycardia 
Space 
Shuttle 
PVCs, PACs PVCs, PACs 
(Fritsch-Yelle et al. 
1996a) 
PVCs, PACs, 
sustained 
ventricular 
bigeminy, 
blocked P-waves 
PVCs, PACs  
Mir PACs, PVCs  
(Gontcharov et 
al. 2005; 
Kotovskaia and 
Vil’-Villiams 
2007) 
PACs, PVCs during 
rest and 
exercise(Gontcharov 
et al. 2005).  One 
evacuation due to 
arrhythmia 
(Bogomolov et al. 
2009).  14-beat run 
of ventricular 
tachycardia (Fritsch-
Yelle et al. 1998) 
PACs, PVCs 
(Gontcharov et 
al. 2005) 
  
ISS Not reported Not reported Not reported Not reported Not reported 
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1.  NASA Spaceflight Experience 
Leguay and Seigneuric (Leguay and Seigneuric 1981) compiled some of the reports 
from the pre-Shuttle era of human spaceflight. At the time, various arrhythmias had been 
observed during spaceflight, but in general there had been no adverse consequences. With 
the exception of the Lunar Module Pilot on Apollo 15,  little attention had been paid to 
these events. 
The Mercury Program consisted of 6 single-person flights, with durations as short as 
15 minutes and as long as 34 hours, with the first mission occurring in May 1961 and the 
final mission completed in May 1963 (Berry 1968). The Gemini Program encompassed 
10 spaceflights from March 1965 to November 1966 (Berry 1968). Two astronauts 
participated in each flight; the shortest mission was just under 5 hours and the longest 
was almost 4 days. Six of the missions included EVA. The first EVA was performed on 
Gemini IV and lasted just 36 minutes; the longest EVA was performed on the final 
mission of the Gemini Program and was 5.5 hours long. There were no reports of 
significant arrhythmias during these missions (Anzai et al. 2014). 
The Apollo Program, NASA’s third human spaceflight program, consisted of 11 3-
man missions between 1968 (Apollo 7) and 1972 (Apollo 17) with the specific goal of 
landing humans on the Moon. Nine of the missions carried humans beyond low Earth 
orbit, and of these, 6 missions landed on the Moon. Each lunar landing mission, 
beginning with Apollo 11, also included EVAs, with each successive mission 
incorporating longer and more complex mission objectives. It was in the course of the 
Apollo program that the first clinically significant arrhythmia was reported (Anzai et al. 
2014). One crewmember during Apollo 15 experienced a 22-beat nodal bigeminal 
rhythm, which was followed by atrial premature beats (Rossum et al. 1997). This 
crewmember reported extreme fatigue during the incident, but only reported the incident 
when questioned by crew surgeons; thus, it was not severe enough to impact the mission. 
Twenty-one months later the crewmember suffered from coronary artery disease and a 
cardiac infarction (Leguay and Seigneuric 1981).  
Skylab was NASA’s first space station; it was visited by 3 separate 3-man crews 
between May 1973 and February 1974 with mission lengths of 28, 59, and 84 days. 
During the Skylab missions, several instances of ventricular PVCs, supraventricular 
PVCs, and nodal arrhythmia were recorded. The arrhythmias occurred during effort tests, 
EVAs, LBNP sessions, and throughout the entire mission. These included 2 consecutive 
PVCs when an astronaut was exercising and an episode of atrioventricular dissociation 
preceded by sinus bradycardia in 2 astronauts (Leguay and Seigneuric 1981). 
One hundred thirty-five Space Shuttle missions occurred over the course of 30 years 
between April 12, 1981 and July 8, 2011, beginning with Space Transportation System 
(STS) 1 and ending with STS-135. During the first 4 flights (called test flights), ECG was 
monitored continuously, and frequent PVCs were observed in 2 crewmembers during 
reentry  and landing (Charles et al. 1996). In subsequent missions routine ECG 
monitoring was conducted only during EVA. According to Charles et al (Charles et al. 
1996), one third of the astronauts who flew before 1996 experienced either PACs or 
PVCs while participating in EVA. Notable ECG findings during EVA were reported in 2 
crewmembers: one with 10 minutes of sustained ventricular bigeminy and the other with 
episodes of frequent PACs. 
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Two studies of cardiac rhythm disturbances were performed in response to medical 
reports of arrhythmias occurring in 9 of 14 Shuttle EVA astronauts between 1983 and 
1985. Rossum et al. (Rossum et al. 1997) reviewed 24-hour Holter recordings acquired 
during and after high altitude chamber training, underwater training for EVA (Weightless 
Environment Training Facility; WETF), 30 days before launch, during and after each 
EVA, and on return to Earth. The investigators observed no change in the number of 
PVCs or PACs per hour during flight compared to preflight or postflight (Figure 2). 
Fritsch-Yelle et al. collected 24-hour Holter recordings from 12 astronauts before, during, 
and after 6 Space Shuttle missions lasting 5-10 days (Fritsch-Yelle et al. 1996a). There 
was a significant decrease in the number of PVCs per hour and a trend toward a decrease 
in the number of PACs per hour compared to preflight. In this report no results for 
individual astronauts were discussed, and some astronauts experienced no dysrhythmias 
throughout the study. 
 
 
Figure 2.  Number of premature atrial (PAC) and ventricular (PVC) contractions before, 
during and after Space Shuttle flights (Rossum et al. 1997).  
 
In the NASA-Mir program, in which 7 NASA astronauts participated in missions 
with 12 Russian cosmonauts, ECG monitoring revealed episodic arrhythmias in 10 of the 
19 crewmembers, with a range of incidence across crewmembers (Gontcharov et al. 
2005). Atrial and ventricular arrhythmias were observed when crewmembers were at rest, 
exercising, and performing EVA. Arrhythmias also were observed in the same 
crewmembers during preflight training. In-flight Holter monitoring recorded an isolated 
incident of a non-sustained 14-beat ventricular tachycardia in one of the crewmember 
(Figure 1), with a maximum heart rate of 215 beats per minute (Fritsch-Yelle et al. 
1998). This cosmonaut experienced a single occurrence of a similar event during a 
previous mission (Gontcharov et al. 2005). Although not part of a systematic scientific 
study, this case provided evidence of arrhythmias during long-duration spaceflight 
(Baevsky et al. 2007).  
The ISS has been continuously inhabited since the arrival of Expedition 1 on 
November 2, 2000. Crews have consisted of as few as 2 and as many as 6 astronauts and 
cosmonauts. One of the specific aims of the Integrated Cardiovascular Study (Principal 
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Investigators: Benjamin Levine, University of Texas, Southwestern Medical Center, and 
Michael Bungo, University of Texas Health Science Center) was to investigate the 
number of arrhythmias occurring in ISS astronauts using 24-h Holter recordings obtained 
before, during, and after the mission. These results have yet to be published, but  
preliminary results presented in the final report to NASA suggest that the majority of 
astronauts participating in these long-duration missions did not have an increase in the 
number of arrhythmias, although 2 of the 13 participants did have increased frequency of 
arrhythmias (Levine and Bungo 2015). One crewmember had a substantial increase in the 
number of supraventricular arrhythmias, and another crewmember experienced an 
increase in ventricular arrhythmias. The investigators have suggested that there may be a 
subset of individuals who may be more susceptible to an increased incidence of 
arrhythmias, but no data yet are available to substantiate this claim or to suggest a 
validated mechanism. A key objective for future exploration missions may be to identify 
the phenotype and the stressors that could be responsible for the increases in arrhythmias 
that occur in certain individuals (Romero et al. 2015). Unfortunately, no continuous ECG 
data were collected from the 2 ISS astronauts who were on-orbit for 340 days in 2016 and 
2017, which could have provided more recent data regarding stays in weightlessness 
similar to durations expected to be required for a mission to Mars.   
 
2.  Soviet and Russian Experience 
A large amount of Soviet-era spaceflight results, including human research data, have 
not been published or observations widely disseminated (Bogomolov et al. 2009). Until 
the Apollo-Soyuz Test Project, space medicine practices at NASA and in the Soviet (later 
Russian) space programs developed independently. Cooperation and exchange of 
information between the two space programs manifested as the U.S.-USSR Joint 
Working Group on Biology and Medicine in the early 1970s and the NASA and Russian 
space programs jointly prepared for the NASA-Mir Program in the early 1990s. A 1992 
agreement between the U.S. and the Russian Federation paved the way for a series of 
joint spaceflight missions from 1994 to 1998 (Bogomolov et al. 2009). Joint missions 
included 7 Russian cosmonauts participating in Space Shuttle missions and 7 NASA 
astronauts participating in long-duration missions on the Mir Space Station. 
Romanov et al. (Romanov et al. 1987) reviewed electrophysiology results from 
Soviet and Russian spaceflight missions between 1964 and 1985 and reported 
observations of supraventricular and ventricular premature beats, with the highest 
reported frequency occurring during launch and the first hours of the mission. Whereas  
most in-flight arrhythmias have been considered not to be clinically significant, one 
cosmonaut  returned before the planned end of his mission because of persistent 
supraventricular tachycardia (Bogomolov et al. 2009). ECG changes that were observed 
after these missions generally resolved during re-adaptation phase, but 3 cosmonauts later 
demonstrated ECG consistent with ischemic heart disease (Romanov et al. 1987). In a 
separate study, cosmonauts who completed a one-year mission on the Mir Space Station 
participated in a 24-h Holter data collection in the first 24 h after landing.  Each 
cosmonaut had infrequent episodes of isolated ventricular extrasystole (Grigoriev et al. 
1991). 
It is unknown whether long-duration exposure to weightlessness itself may precipitate 
cardiac arrhythmias. Based on observations and clinical judgment medical operations 
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personnel have suggested that some of these incidents may have been related to pre-
existing, undiagnosed coronary artery disease. Additional pre-selection tests to screen 
astronauts and cosmonauts before selection and flight assignments, including coronary 
artery calcium scoring, have been added to reduce such occurrences in the future.   
 
3.  Launch and Landing 
Launching into and landing from space are significant physical and psychological 
stressors that historically were significant sources of concern for the development of 
arrhythmias. It has been common practice for NASA and the Soviet/Russian spaceflight 
programs to monitor the crewmembers’ ECG. Kotovskaia et al. (Kotovskaia and Vil’-
Villiams 2007) reported that individuals who exhibited arrhythmias in the preflight 
period also had similar arrhythmias during launch and entry into weightlessness. 
Kotovskaia et al. (Kotovskaia and Vil’-Villiams 2007) compared ECG data from non-
professional cosmonaut visitors (29-60 years old) and medically-qualified cosmonauts 
(31-49 years old) that were obtained during reentry on the Soyuz spacecraft after short-
duration stays on  ISS (8-12 d). The non-professional flyers, particularly the older ISS 
visitors, had higher heart rates and more frequent arrhythmias than the cosmonauts. Less 
rigorous medical screening for nonprofessional space visitors may have contributed to 
this disparity. 
Perez et al. (Perez et al. 2003) trained 34 Space Shuttle astronauts to instrument 
themselves with continuous ECG for the measurements of heart rate and with a brachial 
cuff for automated blood pressure measurements. Measurements were obtained before 
flight, and astronauts donned the instrumentation while on-orbit to obtain data during 
reentry and immediately after landing. The primary objective of this study was to 
determine the effectiveness of the anti-gravity suit (g-suit), and thus no specific analyses 
for arrhythmias were performed. 
Tests have been conducted to assess ISS crewmembers’ ability to complete simulated 
exploration mission-specific tasks soon after landing.  These data are still being collected 
and analyzed. There were no specific analyses for arrhythmias during testing after Space 
Shuttle missions, but clearly some arrhythmias were present in those participants. The 
authors reported that they ignored the influence of ectopic beats (removed them from the 
Holter files) in their analysis of heart rate and autonomic function (Arzeno et al. 2013). 
The nature and frequency of these arrhythmias were not described. 
 An understudied aspect of the arrhythmia risk is whether individuals who 
experience more frequent arrhythmias during spaceflight recover (have fewer 
arrhythmias) after the mission, and what is the time course of this recovery. This is an 
important element of our understanding of the long-term health risks associated with 
spaceflight; this aspect may influence the health care and treatment of astronauts in the 
future (Romero et al. 2015). 
 
4.  Exercise 
No specific flight rules exist to discourage strenuous exercise countermeasures during 
short- or long-duration spaceflight; in fact, high-intensity, interval exercise, characterized 
by periods of near maximal, maximal, and supramaximal efforts alternating with low-
intensity efforts, have been prescribed for astronauts in the Space Shuttle, Mir, and ISS 
programs (Siconolfi et al. 1994; Hayes et al. 2013; Loehr et al. 2015; Kozlovskaya et al. 
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2015) because of the demonstrated efficacy of these exercises in spaceflight analogs 
(Greenleaf et al. 1989; Lee et al. 2007, 2009; Hastings et al. 2012). Heart rhythm is not 
monitored by ECG during routine exercise before, during, or after spaceflight (Moore et 
al. 2010), and therefore arrhythmias are not detected except during clinical tests. ISS 
astronauts are encouraged to wear heart rate sensors to monitor exercise intensity and log 
exercise sessions for medical and research purposes, although this is not a strict 
requirement. Careful evaluation of heart rate logs could be used to screen for abnormal 
R-R intervals, but confirmation of arrhythmias would require ECG monitoring. 
Because of concerns about increasing frequency of arrhythmias and S-T segment 
changes during high intensity exercise, NASA historically has limited exercise testing for 
medical and research objectives to work rates less than or equal to 85% of preflight 
maximal oxygen consumption (Trappe et al. 2006; Moore et al. 2010), except in specific, 
well-controlled cases. Routine exercise tests on NASA vehicles generally have been 
submaximal, and similar constraints on exercise tests are employed in Russian missions, 
particularly during the first week of a mission (Kozlovskaya et al. 1995) and after landing 
(Fortney et al. 1998). During early ISS missions, NASA astronauts participated in 
monthly submaximal exercise tests, consisting of 5 minutes of rest followed by three 5-
minute stages of exercise at work rates equivalent to 25%, 50%, and 75% of preflight 
maximal aerobic capacity. In a review of 26 of these exercise tests, Hamilton et al. 
reported no arrhythmias or S-T segment changes (Hamilton et al. 2005). Although not 
specifically reported, no research studies to-date have indicated that exercise tests to 
maximal exertion were terminated due to arrhythmias before, during, or after short- 
(Siconolfi et al. 1994; Levine et al. 1996; Moore et al. 2001; Trappe et al. 2006) or long-
duration spaceflight (Moore et al. 2014, 2015). Similarly, there were no reports of 
arrhythmias leading to test termination during submaximal exercise tests before, during, 
or after short- (Rummel et al. 1973; Rummell et al. 1975) and long-duration missions 
(Moore et al. 2015). That no arrhythmias occurred cannot be discerned from this 
reporting though as that analysis was not the specific objective of these studies. 
Astronauts and cosmonauts routinely participate in a postflight reconditioning 
program, typically during the first  45 days after landing (Kozlovskaya et al. 1995; Loehr 
et al. 2015; Kozlovskaya et al. 2015). Typically, ECG monitoring is not performed during 
these reconditioning sessions, and therefore identification of arrhythmias is not possible.   
 
5.  Lower Body Negative Pressure 
During the Apollo Program, Hoffler et al. (Hoffler et al. 1974; Hoffler and Johnson 
1975) used LBNP or stand tests to measure orthostatic tolerance in 24 male astronauts 
before and after exposure to weightlessness. Although decreased orthostatic tolerance 
was inferred from higher heart rates during these stressors, no significant arrhythmias 
were reported. During the Skylab Program, supraventricular and ventricular beats were 
observed in all crewmembers (Charles et al. 1996). Ectopic beats were more frequently 
observed during greater levels of LBNP, although they also were noted at rest (Hoffler et 
al. 1977). Atrio-ventricular junctional rhythms also were seen in some crewmembers. As 
reported by Hoffler et al. (1977), arrhythmias that occurred during the Skylab LBNP tests 
wer considered clinically significant. 
All Russian crewmembers participate in LBNP countermeasures sessions in the 3 
weeks before landing from a long-duration spaceflight. This simulates the fluid shifts and 
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cardiovascular stresses associated with standing in normal gravity (Wolthuis et al. 1974) 
as well as stimulating support areas on the soles of the feet (Kozlovskaya et al. 1995, 
2015).  A Russian flight surgeon is available on console to monitor the crewmembers’ 
ECG and blood pressure in real time. The protocol used for this countermeasure was 
developed from a series of bed rest studies, in which  subjects were placed in a head-
down tilt position for 14 to 182 days (Kozlovskaya et al. 1995). 
 
6.  Ground-Based Prevalence of Atrial Arrhythmias  
Prior to 2010, 17 astronauts had presented with atrial arrhythmias out of a total cohort 
of 317 active and retired astronauts, which represents a prevalence of approximately 5% 
(Barr 2010). No arrhythmias were recorded during flight, and most cases were 
asymptomatic. Of these, 5 individuals presented with atrial arrhythmias between 2001 
and 2010 and received radiofrequency ablation treatment. This prevalence of atrial 
fibrillation is not substantially different from rates reported for the general population 
(Abdulla and Nielsen 2009); however, because of more recent cases NASA organized 
and convened the Atrial Arrhythmia Summit on January 22, 2010, to solicit expert 
opinion (Barr 2010). Summit panel members and attendees, experts in the fields of 
electrophysiology, cardiology, aerospace medicine, and epidemiology, were given the 
charge of reviewing cases of atrial arrhythmias in astronauts with the intent of providing 
recommendations regarding screening, diagnosis, and treatment of the astronaut corps; 
determining lifestyle and spaceflight-related factors that might predispose astronauts to 
atrial arrhythmias; and assessing risks to astronauts who participate in long-duration 
spaceflight or extravehicular activities after treatment.   
While the prevalence of atrial arrhythmias was not stated as a significant concern, the 
age of presentation was lower in astronauts than in the general population (~40 vs. ~60 
years old (Abdulla and Nielsen 2009) (Barr 2010). The panel suggested two factors that 
could account for earlier than expected presentation of atrial arrhythmias: more frequent 
and comprehensive screenings in the astronaut corps in the form of annual physicals 
leading to a higher discovery rate; and greater levels of vagal tone associated with a high 
frequency and duration of aerobic exercise performed by astronauts (Wilhelm 2014). 
Although exercise is not rigorously controlled or prescribed for astronauts when they are 
not in space, when NASA astronauts are assigned to an ISS mission they specifically are 
allotted 4 hours of preflight exercise training in their weekly preflight schedule, and they 
work directly with the Astronaut Strength, Conditioning, and Rehabilitation specialists 
(ASCRs) (Loehr et al. 2015); astronauts who are not in the preflight training  program are 
encouraged to maintain regular exercise habits. In middle-aged non-elite distance runners 
of similar age range as the average astronauts (40-50 years old) lifetime training volume 
is associated with increased vagal tone, prolongation of signal-averaged P-wave duration, 
and an increase in left atrial volume (Wilhelm et al. 2011a). Adaptations such as these, 
coupled with a higher systolic blood pressure, are more pronounced in men than women 
and may explain the different rates of atrial fibrillation associated with sex (Wilhelm et 
al. 2011b). Other investigators have noted an association between exercise volume and 
risk of atrial fibrillation in men but not in women (Zhu et al. 2016). 
In general, astronauts are perceived to be fitter than the general population. For 30 
male and 7 female astronauts who participated in preflight cycle ergometry testing to 
maximal exertion before their mission in the first 10 years of the ISS program 
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(Expeditions 1-25), the average aerobic capacity was 44±8 and 41±7 ml/kg/min, 
respectively (Moore et al. 2015). With an average age of 46±4 and 43±3 years in these 
men and women, respectively, the average crewmember’s aerobic capacity represents 
percentile ranking of ~60th in men and >80th in women (American College of Sports 
Medicine 2013).  Similarly, moderate to high levels of aerobic fitness were observed in 9 
men and 5 women astronauts who participated in Expeditions 19 through 33; their 
average aerobic capacity was ~41 ml/kg/min, and their average age was 49 years (Moore 
et al. 2014). These values are within the same range as  previously reported data from 3 
studies conducted in Space Shuttle astronauts, in which the mean preflight aerobic 
capacity across studies ranged from 38 to 48 ml/kg/min in a total of 15 men and 3 women 
(Levine et al. 1996; Moore et al. 2001; Trappe et al. 2006). 
While the Atrial Arrhythmia Summit panel concluded that there was no evidence that 
spaceflight-related factors contribute to the development of atrial arrhythmias during 
spaceflight, they speculated as to which specific factors might be of concern: 
weightlessness-induced cephalad fluid shifts resulting in atrial distension; spaceflight-
induced increase in sympathetic activation; plasma volume expansion secondary to 
elevated dietary sodium intake in salt-sensitive individuals due to the use of sodium as a 
food preservative for spaceflight missions; and chronic radiation exposure. 
 
B.  Ground-Based Evidence 
In general, bed rest subjects do not exhibit increases in ventricular ectopy, although 
one study has suggested a potential for increased susceptibility based on microvolt T-
wave alternans (MTWA) assessed during a graded exercise test. After 9 to 16 days of bed 
rest, the number of subjects who were MTWA positive increased from 17% (4 of 24) 
before bed rest to 42% (10 of 24) after bed rest (Grenon et al. 2005); 2 of the 4 subjects 
who were categorized as MTWA positive before bed rest became MTWA negative, while 
8 who were negative before bed rest were categorized as MTWA positive after bed rest. 
However, MTWA was not present in any subject who had a heart rate below 110 bpm, 
the threshold for which MTWA would be considered clinically significant. Clinically 
significant MTWA is associated with cardiac arrest, sudden death, and ventricular 
arrhythmias in patient populations (Rosenbaum et al. 1994; Ikeda et al. 2002). 
   Numerous studies have shown decreases in left ventricular mass and/or volume 
during bed rest as an analog of spaceflight (Levine et al. 1997; Perhonen et al. 2001; 
Arbeille et al. 2001; Dorfman et al. 2007; Westby et al. 2016). Left ventricular mass has 
been shown to decrease by 8 percent after 6 weeks of bed rest, which was thought to be 
related to decreased physiological loading (Perhonen et al. 2001). Although decreases in 
left ventricular mass would be expected to contribute to decreased orthostatic tolerance 
(Levine et al. 1997) and exercise capacity (Dorfman et al. 2007), to our knowledge no 
post-bed rest exercise testing has been terminated as a result of arrhythmias (Lee et al. 
2010). 
Ground-based animal studies have determined the effects of simulated weightlessness 
on the cardiovascular system. Tachycardia has been observed in standing rats, after 
hindlimb unloading for 28 days (Ray et al. 2001). Decreased cardiac mass has also been 
documented in studies of hindlimb-suspended rats (Bao et al. 1999). However, 
hemodynamics in humans differ from hemodynamics in quadrupeds; thus, the rat is not 
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the most appropriate model in which to examine weightlessness-induced cardiovascular 
adaptations (Rowell 1993). 
Recently, mice that were hindlimb suspended for 28-56 days were found to have 
enlarged hearts with decreased contractility as well as an increased susceptibility to 
pacing-induced arrhythmias as detected by echocardiography (Respress et al. 2014). 
Further, cardiomyocytes harvested from the tail-suspended animals demonstrated an 
increased leakiness of calcium from the sarcoplasmic reticulum, as well as increased 
frequency of spontaneous calcium release that may have been caused by elevated 
phosphorylation of the ryanodine receptor (RyR2). 
 
C.  Contributing Factors 
Despite previous reports describing the occurrence of arrhythmias during spaceflight, 
the notion that exposure to weightlessness is a specific causative factor has been 
challenged (Convertino and Cooke 2005; Convertino 2009). However, factors associated 
with crew health as well as adaptation to weightlessness and the spaceflight environment 
should be considered (Gontcharov et al. 2005). 
 
1.  Preflight Condition 
The episode of ventricular tachycardia that occurred in one Mir crewmember, while 
concerning for the crewmember, does not in and of itself provide solid evidence that 
spaceflight is arrhythmogenic, especially given that previous episodes had been observed 
in this individual (Convertino and Cooke 2005). During the NASA-Mir Program, all 10 
astronauts and cosmonauts who  experienced atrial or ventricular arrhythmias during their 
mission  had similar findings during their preflight training, although the episodes were 
perhaps less frequent or severe before launch (Gontcharov et al. 2005). Further, the 
crewmember who experienced a run of ventricular tachycardia during his NASA-Mir 
mission (Fritsch-Yelle et al. 1998) had a similar event during a previous mission, and one 
crewmember who had S-T segment depression during EVA had similar S-T segment 
changes before launch (Gontcharov et al. 2005). 
A review of ECG records from 30 cosmonauts who participated in long-duration 
missions (73-197 days in duration) on either Mir or ISS determined that the majority of 
the crewmembers (70%) did not exhibit arrhythmias during preflight training, launch, or 
reentry, and a few (10%) who had arrhythmias before flight did not have arrhythmias 
during launch or landing (Kotovskaia et al. 2008). However, a small number of 
individuals had increased frequencies of rhythm and conduction disturbances during 
reentry that were not observed during preflight training. 
Data from early spaceflight missions should be interpreted with caution because 
attitudes toward dietary and cardiovascular health habits have evolved over the history of 
the space program. For example, individuals who were considered very healthy in the 
1960s may have been habitual smokers, whereas fewer astronauts smoke now. Further, 
cultural attitudes regarding health and wellness differ among international partner 
countries. 
 
2.  Age and Gender 
As of 2005, the average age of an individual who was selected for the astronaut corps   
was 36 and 35 years for men and women, respectively, and the average age of the active 
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astronauts was 45 and 44 years for men and women, respectively (Hamilton et al. 2005). 
Thus, most astronauts are “middle-aged” by the time they fly in space, and are likely to 
experience age-related health effects. Whereas spaceflight crews now include more 
women than ever (women now constitute ~20% of the current active NASA astronaut 
corps), the majority of the astronauts and cosmonauts who fly in space are middle-aged 
men (Harm et al. 2001; Platts et al. 2014), who, because of their age and sex, are more 
likely to experience dysrhythmias and have subclinical manifestations of cardiovascular 
disease. 
  
3.  Fluid Shifts 
Entry into weightlessness causes cephalad fluid shift (Thornton et al. 1977, 1987), 
which initially results in distension of the cardiac chambers (Buckey et al. 1996; 
Videbaek and Norsk 1997; Corsi et al. 2002; Caiani et al. 2006) that resolves somewhat  
(Arbeille et al. 2001) as the body fluids are redistributed and blood and plasma volume 
decrease (Leach et al. 1996; Meck et al. 2001). That is, although stroke volume and 
cardiac output initially increase in weightlessness, they return to near preflight standing 
levels over the first few days of flight (Prisk et al. 1993). Similarly, others have reported 
no change or a decrease in stroke volume and cardiac output during long-duration 
spaceflight compared to preflight levels at supine rest (Herault et al. 2000; Hamilton et al. 
2011). In contrast, Norsk et al. (Norsk et al. 2015) recently reported that cardiac output 
and stroke volume after 3 months of weightlessness are increased by more than 30% 
relative to measurements taken preflight at seated rest. Further, although not a direct 
measure of atrial distension, internal jugular vein cross-sectional area also is increased 
during short- and long-duration spaceflight (Herault et al. 2000; Arbeille et al. 2001) and 
internal jugular venous pressures increased during parabolic flight (Martin et al. 2016). 
Additionally, a small amount of data from parabolic flight and spaceflight (Summers et 
al. 2010) and preliminary observations from a recent ISS investigation suggest that the 
cardiac chambers appear to become more spherical in weightlessness, which might 
influence cardiac remodeling.  
 
4.  Reduced Cardiac Mass  
Evidence suggests that apoptosis, or “programmed cell death” occurs in response to 
pathological, physiological, and/or genetic signals, and this may be a key mechanistic 
factor in the development of cardiac arrhythmias. For example, apoptosis associated with 
atrophy and fibro-fatty replacement of right ventricular tissue has been identified as the 
likely mechanism for arrhythmia development in arrhythmogenic right ventricular 
dysplasia, a condition that may lead to sudden death in otherwise healthy young 
individuals (Basso et al. 1996; Mallat et al. 1996). 
Indications of reduced cardiac mass as a result of stays in weightlessness were 
observed in early NASA spaceflight programs. Postflight cardiothoracic ratio, calculated 
from the posterior/anterior chest X-rays, was reduced in 24 of 30 Apollo astronauts with 
a mean loss of 5% (Hoffler et al. 1974; Hoffler and Johnson 1975). These data provided 
only a quantitative measure of the dimensions of the heart as a whole, and therefore it is 
not possible to determine specific changes in chamber dimensions or myocardial mass 
with these measures. 
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Multiple investigators have also reported decreased cardiac mass, particularly in the 
left ventricle, following chronic exposure to simulated spaceflight (Levine et al. 1997; 
Perhonen et al. 2001; Spaak et al. 2005; Dorfman et al. 2007; Shibata et al. 2010; 
Hastings et al. 2012; Carrick-Ranson et al. 2013), with the magnitude of cardiac atrophy 
associated with the duration of exposure (Westby et al. 2016). Additionally, results from 
a small number of women suggest that sex does not affect the magnitude or time course 
of cardiac atrophy (Tuday and Berkowitz 2007; Dorfman et al. 2007; Westby et al. 2016). 
However, the effects of unloading can be prevented by exercise alone (Shibata et al. 
2010; Hastings et al. 2012; Carrick-Ranson et al. 2013) or in combination with 
orthostatic-like stress (Dorfman et al. 2007). 
 
 
Figure 3. Left ventricular mass measured by magnetic resonance imaging before and 
after short-duration spaceflight.  Lines represent results from individual astronauts (n=4).  
The average response (mean +/- SD) is represented by circles. 
 
Although most astronauts routinely performed exercise during Space Shuttle missions 
(Hayes et al. 2013), there are reports of decreased left ventricular mass after short-
duration spaceflight. Perhonen et al. (Perhonen et al. 2001) reported that left ventricular 
mass on average tended to be less following a 10-day Space Shuttle mission (-12%, 
p=0.07), but there was substantial individual variability among these astronauts. Left 
ventricular mass decreased from pre- to postflight in 3 of 4 astronauts (measured using 
cardiac magnetic resonance imaging on landing day (Error! Reference source not found.), 
but one astronaut experienced an increase in LVM of ~7%.  Importantly, this crew 
performed little to no exercise during the course of their mission other than that required 
for participation in other experiments. Summers et al. (Summers et al. 2007) used 2-
dimensional echocardiography to assess left ventricular mass on landing day after Space 
Shuttle missions and reported decreases in mass similar to those reported by Perhonen et 
al. (Perhonen et al. 2001), although full recovery had occurred  days after landing 
(Figure 4). 
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Figure 4. Left ventricular mass before and after short-duration spaceflight (n=38) drawn 
from Summers et al. 2005.  * = p ≤ 0.05.   
 
Currently no published reports exist  regarding the effects of long-duration 
spaceflight on cardiac mass and volume. Unpublished data (Platts et al., NASA Johnson 
Space Center, Cardiovascular and Vision Laboratory) suggest decreased left ventricular 
mass after 4-6 months of spaceflight during the early ISS missions. In these subjects, the 
reduction in left ventricular mass was double that observed after short flights, and 
ventricular mass did not fully recover by the third day after landing (Figure 5), as had 
been reported by Summers et al. (Summers et al. 2007) following short-duration 
missions. It has yet to be reported in the peer-reviewed literature whether these changes 
persist after exercise countermeasure hardware was improved (Korth 2015) and the 
intensity of exercise countermeasures was increased (Loehr et al. 2015). However, one of 
the specific aims of the Integrated Cardiovascular Study (Principal Investigators:  
Benjamin Levine, University of Texas, Southwestern Medical Center, and Michael 
Bungo, University of Texas Health Science Center) was to investigate whether 
cardiovascular mass and volume in ISS astronauts is a contributing factor for cardiac 
arrhythmias (Levine and Bungo 2015). Preliminary results presented in their final report 
to NASA indicate that, on average, ventricular mass did not change significantly from 
pre- to postflight in the 13 astronauts studied, but there was considerable variability in 
this effect. Pre- to postflight changes in left ventricular mass were directly related to the 
pre- to in-flight change in cardiac work (calculated from 24-hour recordings of heart rate 
and finger blood pressure), and it is likely that the largest influence is from varying levels 
of performance of in-flight exercise countermeasures.  Additionally, these investigators 
noted that there was no evidence of focal scarring or diffuse fibrosis from MRI that might 
be indicative of cardiac injury. 
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Figure 5.  Left ventricular mass before and after long-duration spaceflight (n=6) drawn 
from unpublished data from Platts et al., NASA Johnson Space Center, Cardiovascular 
and Vision Laboratory.  * = p ≤ 0.05.   
 
There has been some disagreement over the mechanism that causes decreases in 
ventricular mass, especially after short-duration missions. Evidence exists that supports 
the concept that tissue dehydration contributes to the loss in mass after short-duration 
spaceflights (Perhonen et al. 2001), but this factor likely does not fully explain losses 
after long-duration missions. However, there are data from bed rest studies showing that 
the decrease in mass can be prevented with exercise and/or nutritional countermeasures 
(Dorfman et al. 2007). 
 
5.  QT Prolongation 
The QT interval is a measure of the combined duration of ventricular depolarization 
(QRS) and repolarization (T wave). The QRS complex is usually of fixed duration in 
healthy individuals. Thus, changes in QT duration represent alterations in ventricular 
repolarization. The QT interval of the surface ECG is a spatial and temporal summation 
of all cardiac cellular action potentials. Not all cells within the heart share identical action 
potentials; therefore, a certain degree of variability, or inhomogeneity exists in their 
repolarization time. The degree of inhomogeneity during repolarization directly correlates 
with the overall morphology of the QT waveform (primarily the T-wave) and in most 
cases with the QT interval duration. A clear association between the magnitude of 
inhomogeneity of repolarization and the risk for the development of ventricular 
arrhythmias has been established (Lux et al. 2001; El-Sherif 2001; Shusterman et al. 
2006).   
The QT interval is often corrected for heart rate and is shown as QTc. Some 
conditions that can prolong the QTc interval are ischemic heart disease, autonomic 
dysfunction, bradycardia, electrolyte abnormalities, cardiac remodeling, and diuretic 
medications that interfere with the cardiac potassium ion channels (Ishida et al. 1995; Lo 
et al. 1996; Savelieva et al. 1999; Haverkamp et al. 2000; Khan 2002). Which of these 
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factors are seen in long-duration astronauts? First, it is known that astronauts develop 
changes in the autonomic nervous system (Fritsch et al. 1992; Fritsch-Yelle et al. 1996b; 
Meck et al. 2001; Rossum et al. 2001). Second, on long-duration flights, astronauts have 
a relative bradycardia compared to astronauts on short-duration flights (Meck et al. 
2001). Third, there is evidence of cardiac remodeling after long-duration flights. Fourth, 
there are medications available to astronauts aboard the ISS that prolong QTc interval, 
including ciprofloxacin, haldol, inderal, verapamil, zithromax, Zoloft®, and nortriptyline. 
The environment created by the combination of factors listed above might cause or 
exacerbate the prolongation of the QT interval.   
Prolongation of QTc interval does not itself guarantee an increase in ventricular 
arrhythmias. For example, sleep, hypothyroidism, and use of the anti-arrhythmic drug 
amiodarone all prolong QTc without increasing the incidence of ventricular arrhythmias. 
It is possible that spaceflight presents a similar situation; however, at this time, the 
determination cannot be made due to lack of data. The finding of QTc prolongation in 
astronauts has been of concern from the clinical operations perspective. Such 
prolongation has been documented on several occasions but it is not clear whether  these 
findings have any clinical significance or portend risk (D’Aunno et al. 2003; Mitchell and 
Meck 2004).  
 
6.  Electrolyte Disturbances 
Cardiac rhythm abnormalities and exercise intolerance observed in the Apollo 15 
Lunar Module Pilot were attributed at the time to electrolyte disturbances, particularly 
hypokalemia (Leguay and Seigneuric 1981). Inadequate potassium intake was suspected, 
and before Apollo 16 a 12-day bed rest study with low potassium intake was conducted 
with 2 subjects as a simulation of the Apollo 15 mission. The study included replication 
of the crew’s sleep schedule and caloric intake (Hyatt et al. 1975). However, neither of 
the bed rest subjects developed symptomatic hypokalemia, only one demonstrated minor 
ECG abnormalities, and the decrease in exercise capacity and orthostatic tolerance in 
these subjects was no more than expected for a bed rest of similar duration with normal 
dietary intakes. 
Serum and urinary potassium levels decreased by 7% and 47%, respectively, in both 
Apollo crewmembers (Leach et al. 1975), but a later review of the Apollo 15 mission 
suggested that magnesium deficiency contributed to the arrhythmias and other symptoms 
(Rowe 1998). However, data from short- and long-duration spaceflight may not support 
the contention that chronic low magnesium levels as a significant cardiovascular risk 
factor during spaceflight. Although their results are  not specific to Apollo 15, Smith and 
Zwart (Smith and Zwart 2015) report that during long-duration ISS missions, urinary 
magnesium concentrations were elevated within the first 2 weeks of the mission and 
serum levels were elevated above preflight levels after 3-4 months of flight. Both urinary 
and serum magnesium decreased and were lower than preflight values on landing day but 
then returned to preflight levels within 1 month after landing. Despite these dynamics, 
tissue levels of magnesium, measured in epithelial cells from sublingual scrapes, were not 
different from preflight values on landing day or 1 month after landing. After short-
duration spaceflight, neither urinary nor serum magnesium levels were different from 
preflight values. 
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Prolonged QTc intervals observed after long-duration, but not short-duration, 
spaceflight were not associated with clinically relevant changes in electrolyte levels 
(D’Aunno et al. 2003). In 5 Shuttle and 7 Mir astronauts, there was no pre- to postflight 
change in serum magnesium or calcium levels; although serum potassium measured on 
landing day was significantly less than before flight, the levels were still within clinical 
normative ranges.   
 
7.  Catecholamines 
Elevated catecholamines and increased sympathetic activity have been associated 
with the development of arrhythmias in terrestrial populations (Leguay and Seigneuric 
1981). Leach et al. (Leach et al. 1996) reported no change in serum catecholamines from 
pre- to in-flight and that urinary norepinephrine levels were lower during Space Shuttle 
missions than before launch. More recently, Norsk et al. (Norsk et al. 2015) reported no 
change in norepinephrine and epinephrine levels from preflight (seated) to in-flight 
during 3-6 month ISS missions. 
 
8.  Oxidative Stress 
A number of studies have suggested that biomarkers of oxidative stress are elevated 
during spaceflight, although the specific source of the oxidative stress is yet to be 
determined (Smith et al. 2009). In the course of a spaceflight mission, astronauts can 
experience oxidative stress that is induced from a variety of conditions, including 
changes in exercise and dietary habits, exposure to high-linear energy transfer radiation, 
psychological stress, and hyperoxic conditions associated with EVA and prebreathe 
protocols that are implemented prior to EVA as a countermeasure for decompression 
sickness (DCS).  A current experiment is measuring vascular structure and function in 13 
astronauts who spend 6-12 months on ISS to determine whether these crewmembers 
exhibit subclinical manifestations of cardiovascular disease and whether a relationship 
exists between vascular adaptations to spaceflight and biomarkers of oxidative stress and 
inflammation (Lee et al. 2017).  Previous work by others has documented increased 
carotid intima media thickness (Arbeille et al. 2016) and carotid artery stiffness (Hughson 
et al. 2016) from before to after long-duration spaceflight.  The work by Lee et al. (Lee et 
al. 2017) is the first to acquire inflight vascular measures and biomarkers to characterize 
the time course of spaceflight-induced adaptations as well as to measure the long-term 
effects on vascular health with measures extending out to 5 years after landing.  Given 
that ionizing radiation is a potent source of oxidative stress and has been associated with 
cardiovascular disease, even at relatively low doses (Little et al. 2012; Little 2016), this 
study of astronauts in low Earth orbit also will serve as an important baseline to which to 
compare findings from astronauts who are exposed to space radiation during future 
exploration missions.  Studying the physiologic and health consequences of different 
levels of radiation from low Earth orbit and travel beyond the van Allen belts is critical to 
the understanding of any synergistic effects of radiation and weightlessness and the 
appreciation of the risks associated to missions to Mars and other destinations. 
EVAs typically last between 4 and 8 hours, and require pre-breathing 100% oxygen 
before the EVA. Acute hyperoxic exposures are associated with increased systemic and 
coronary artery vasoconstriction, both at rest and during exercise. Vitamin C can reverse 
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the effects, which supports the hypothesis that  these effects are mediated by the 
formation of reactive oxygen species (Ranadive et al. 2014). 
NASA has used  prebreathe protocols to lessen the likelihood that astronauts will 
develop decompression sickness when they move from working in the space vehicle in 
which atmospheric conditions are maintained similar to that on Earth (~14.7 psi) to the 
EVA suit. When working in the EVA suit, astronauts must use force to bend the suit at 
the joints which  increases the physical effort and rate of fatigue. The NASA EVA suit, 
the EVA Mobility Unit, which has been used used during the Space Shuttle and ISS 
programs is pressurized to 4.7 psi, and the Russian Orlan spacesuit is pressurized to 3.5 
psi. A variety of prebreathe protocols have been employed by NASA over the years, 
including Shuttle decompression, camp-out, exercise prebreathe, and 4-hour prebreathe. 
The objective of the NASA prebreathe research program has been to reduce time required 
to perform the prebreathe activity while not increasing the likelihood of DCS.  In addition 
to increasing the duration of exposure to a hyperoxic environment, a longer prebreathe 
time decreases the total amount of time that a crewmember can take to perform an EVA. 
 
9.  Prevalence of Cardiovascular Disease in Astronauts 
To date, too few astronauts have presented with chronic diseases to perform an 
accurate analysis of the risk of cardiovascular disease morbidity. Therefore, analyses 
regarding cardiovascular disease have been limited to cardiovascular mortality. However, 
interpretations of the data should still be viewed with caution considering how few 
astronauts there are and how few astronaut deaths are attributable to cardiovascular 
disease. 
In the first study of cardiovascular mortality of astronauts, Peterson et al. (Peterson et 
al. 1993) examined records from 195 astronauts selected between 1959 and 1991 who 
participated  in NASA’s Longitudinal Study of Astronaut Health. Standardized mortality 
ratios (SMRs) are calculated as the ratio of the number of observed deaths in the 
astronaut group to the number of deaths expected in a comparison group; a score of 100 
is considered to demonstrate consistency between the populations compared. Cause of 
death in the astronauts was categorized based on death certificate and autopsy reporting, 
and astronaut death rate was compared to that of the U.S. population, after controlling for 
age, sex, race, and calendar year. Of the 20 astronauts who died before 1991, circulatory 
disease accounted for only 2 (10%) of the reported deaths, and the SMRs in astronauts 
were 47 (95% CI: 5-168) and 64 (95% CI: 7-230) for circulatory disease and ischemic 
heart disease, respectively. Thus, there were no significant differences between the 
astronaut and U.S. populations in these comparisons. By far, accidents accounted for the 
largest proportion of the deaths, with a SMR of 1346 (95% CI: 769-2168). Because these 
data were from early in NASA’s space program, most astronauts were not at an age at 
which cardiovascular disease may have developed. 
A later study of cardiovascular mortality was undertaken to improve upon the validity 
of previous analyses by comparing findings in astronauts to findings from a matched 
group of civil servants employed at the NASA Johnson Space Center (Hamm et al. 2000). 
In a 3:1 ratio of test subjects to astronauts, employees were recruited at the time of each 
astronaut class.  Employees were matched to astronauts by sex, age, and body mass 
index. Data were derived from physical examinations of active astronauts (required 
annually), inactive or retired astronauts (voluntary participation), and the matched cohort 
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(examinations offered every 1-3 years). Cause of death was confirmed by death 
certificate, with these reports supplemented by autopsy reports in astronauts. Hamm et al. 
(Hamm et al. 2000) reported no statistical difference in adjusted relative risk of 
cardiovascular mortality in the astronaut corps. Three of the 195 astronauts and 7 of the 
575 comparison subjects had died from cardiovascular disease, which resulted in a 
relative risk of 1.20 (95% CI: 0.27-5.28). The only difference in mortality between the 
two groups was for accidental deaths (both occupational and non-occupational), with a 
reported adjusted relative risk of 22.7 (95% CI: 5.0-104.5). However, there were several 
potential confounding factors in this study. First, despite best efforts at matching the 
cohort to the astronauts at baseline, astronauts had a higher educational level (% with 
graduate degrees) and rate of smoking, and lower mean values of glucose, triglycerides, 
and hemoglobin, although these latter findings were within clinical normal values. 
Second, some measures of heart and blood pressure were significantly lower in astronauts 
than in the matched cohort, although these differences were small and likely not clinically 
relevant. Factors that could have influenced these results may have been related to 
lifestyle; lifestyle data was not collected at baseline for the majority of the subjects and 
only was included in data collection procedures starting in 1994. Third, 11 of the 
comparison cohort had medical conditions (9 hypertension, 2 diabetes) at baseline that 
would have been disqualifying factors for astronauts. However, only one of these 11 
comparison subjects died during the study period, and analyses excluding these 11 
subjects did not substantially affect the outcomes. Finally, whereas physical examinations 
were conducted by different groups of physicians (astronauts: Flight Medicine Clinic; 
comparison group: Occupational Health Clinic), clinic tests were performed by the same 
technicians to ensure the test were performed consistently.  
In a follow-on study, Reynolds and Day (Reynolds and Day 2010) searched 
publiclyavailable records of cause of death for astronauts who were selected for the corps 
from  1959 to 2004. They determined that the SMR of astronauts dying from circulatory 
diseases was substantially less than that of the general population. Results were 
consistent across separate comparison groups, including the population of the United 
States, Texas, and Harris County (the county in which Johnson Space Center is located). 
The SMR for astronauts was 27 (95% CI: 9-63) when they were compared to Harris 
County residents. Lower rates of cardiovascular mortality in astronauts than in the 
general population likely is related to the extensive medical screening that astronauts 
must undergo before selection, the frequent re-evaluation of their cardiovascular health 
that they must undergo throughout their career through annual and flight qualification 
physicals, and the generally high level of physical fitness that the astronauts are expected 
to maintain (Reynolds and Day 2010). Interestingly, when similar methodology is used 
the SMR for death from circulatory diseases in Soviet era and Russian cosmonauts 
(1960-2013) was SMR  364 (95% CI: 225-557) when they were compared to NASA 
astronauts (Reynolds et al. 2014).  It is possible, however, that the comparisons between 
astronauts and cosmonauts are not appropriate given that historically cosmonauts have 
engaged in longer duration missions, through the Salyut and Mir Space Station programs, 
than NASA astronauts and other culture-related differences in heath behavior exist, 
including alcohol consumption (Shkolnikov et al. 1998). However, interpretation of the 
results from these particular studies are impaired by issues including lack of control for 
lifestyle factors (e.g., diet, smoking, alcohol consumption, stress, exercise habits) and 
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competing risks (e.g., earlier than expected death due to accidents or occupational 
hazards) (Reynolds and Day 2017). 
To date, the vast majority of astronauts have flown only in low Earth orbit where 
radiation exposures are limited by the protective effects of the van Allen Belts and when 
in the shadow of the Earth (Cucinotta et al. 2016). Thus, cardiovascular mortality in 
relation to space radiation exposure can only be assessed in Apollo astronauts who 
traveled to the Moon. In an attempt to quantify the risks of space radiation for 
cardiovascular health, Delp et al. (Delp et al. 2016) compared causes of death in deceased 
Apollo astronauts who had traveled beyond low Earth orbit (n=7) to causes of death for 
deceased astronauts who flew only in low Earth orbit (n=36), and to causes of death for 
deceased individuals who were selected as astronauts but never participated in an orbital 
flight (n=41). The cause of death was obtained from death certificates, official NASA 
sources, obituaries, or other biographical sources. Similar to findings from previous 
reports, the proportional mortality rate due to cardiovascular disease was significantly 
less in astronauts than in the U.S. population of adults between 55 and 64 years old 
(27%). However, the proportional mortality rate from cardiovascular disease for Apollo 
astronauts (43%) was significantly greater than rates in both the low Earth orbit astronaut 
group (11%) and in astronauts who never flew an orbital mission (9%). One strength of 
this study was the comparison to a group of non-flight astronauts who would be expected 
to have more similar baseline characteristics to other astronauts than the general 
population. Otherwise, the work by Delp et al. (Delp et al. 2016) has been widely 
criticized for its overall methodology as well as its conclusions, which were based on a 
small number of subjects (Cucinotta et al. 2016).   
More recently, Reynolds and Day (Reynolds and Day 2017) applied methods similar 
to those in their previous reports to calculate SMR due to cardiovascular disease in the 
Apollo astronauts to address the same question regarding the effects of deep space 
radiation on cardiovascular mortality. After reviewing records for the same Apollo, low 
Earth orbit, and non-flight astronauts, Reynolds and Day (Reynolds and Day 2017) 
reported the opposite conclusions from Delp et al. (Delp et al. 2016), stating that there 
was no evidence of an increased rate of death due to cardiovascular disease in astronauts 
who traveled to the Moon.  Reynolds and Day (Reynolds and Day 2017) reported that 
Apollo astronauts have a SMR of 117 (95% CI: 24-343) when compared to individuals 
who were selected using the same criteria as astronauts but did not fly, and a SMR of 72 
(95% CI: 15-210) when compared to astronauts who only flew in low Earth orbit. 
Further, the SMR of Apollo astronauts (15, 95% CI: 3-43) was lower than that of the U.S. 
population.  
In general, all of this work is limited to computations of mortality risk  with no 
concern for morbidity or the diagnosis of cardiovascular disease. Further, as with all 
spaceflight studies, the number of spaceflight participants is limited and these participants 
have had limited total spaceflight exposure. The corresponding level of statistical 
uncertainty means that definitive conclusions can be drawn only for dramatically large 
spaceflight effects (Reynolds and Day 2017). A full understanding of the cardiovascular 
disease risk associated with spaceflight cannot be attained without full participation of the 
astronaut corps, especially of retirees for whom continued participation in regular 
physical examinations at the Johnson Space Center or reporting of results to NASA has 
been voluntary and without specific benefits.   
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All analyses of cardiovascular mortality reported thus far have a significant 
limitation. Petersen et al. (Peterson et al. 1993) and Hamm et al. (Hamm et al. 2000) 
reported higher than expected SMR among astronauts due to accidents or other external 
causes, which occurred  at a younger average age than death due to natural causes. 
Consequently, it is impossible to determine whether the individuals who died of 
accidental causes would have developed arrhythmias and cardiovascular disease had they 
not died at an early age (Austin et al. 2016). No study to date has controlled for 
competing risks in their analyses. When these competing risks are ignored, the 
assumption of independent censoring is violated, meaning that those who die at a younger 
age are not represented in the population who survive. When these competing risks are 
ignored, the incidence of cardiovascular disease may be overestimated 
The Lifetime Surveillance of Astronaut Heath at the NASA Johnson Space Center is 
currently working to address limitations of previous studies in new analyses of risk of 
cardiovascular mortality and morbidity. Two new comparison cohorts have been 
identified (U.S. Air Force Aviators and Cooper Center Longitudinal Study); subjects with 
more similar baseline characteristics can be chosen from these groups than was possible 
in previous studies so as to address potential selection bias and healthy worker effects. In 
addition, larger numbers and more detailed medical records are available for these 
groups, which should help to control for reporting bias. Information will be drawn from a 
database of 1.2 million records from the Air Force and from 100,000 participants in the 
Cooper Center Longitudinal Study. Separate analyses will be performed for each cohort; 
subjects from each cohort will be selected and matched with individual astronauts in a 
ratio of 3:1 (cohort: astronaut).  
 
V.  RISK IN CONTEXT OF EXPLORATION MISSION 
OPERATIONAL SCENARIOS 
Cardiac rhythm disturbances could jeopardize mission objectives and, at the most 
extreme, the life of crewmembers. The impact of such an event is related to the mission 
phase and the individual affected (Hamilton et al. 2005). Clearly, the most catastrophic 
events would involve the loss of the mission commander or pilot during launch, landing, 
or course correction activities, particularly in situations in which the crew must function 
autonomously with little to no support from the ground. Other scenarios that would be 
particularly serious include a life-threatening arrhythmia during the outbound phase of a 
Mars exploration mission when return to Earth might not be possible for many months or 
during an EVA when assistance from another crewmember would be required and care 
could not be administered until the EVA suit is removed inside the vehicle or habitat 
(Grigoriev et al. 2009). Under these conditions, other crewmembers would need to treat 
the affected crewmember using the limited resources and finite supplies available on the 
spacecraft or in the habitat. While it is assumed that one or more crewmembers will have 
medical training, it cannot be guaranteed that the affected crewmember is not the 
physician or crew medical officer.  
That there is the potential for a serious medical event to be a concern for exploration 
missions is illustrated by past events. For example, the incidence of significant medical 
concerns was calculated to be 0.07 events per person year over an 11-year period on the 
Mir Space Station. During this 11-year period, there were 30 initial reports of 
arrhythmias or conduction defects, and 98 reports of recurrence (Goncharov et al. 2004). 
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Of these, one cosmonaut was evacuated from Mir in 1987 6-months into an 11-month 
mission, because of a persistent supraventricular tachycardia (Marshburn 2008; Grigoriev 
et al. 2009), and another cosmonaut received medications for cardiac ischemia during his 
mission (Marshburn 2008).   
 
D.  Primary Prevention (Screening) 
To prevent a serious arrhythmia from occurring during a spaceflight mission, 
selection of astronauts with a low cardiac risk profile could be considered a primary 
prevention strategy (Hamilton et al. 2005). As an illustration, an Apollo 15 crewmember 
experienced a myocardial infarction 21 months after the mission during which significant 
arrhythmias were observed. This raised concerns that the crewmembers should be more 
carefully screened for occult cardiovascular disease before each mission (Leguay and 
Seigneuric 1981). Even so, astronauts and cosmonauts have participated in rigorous 
medical screenings, including those targeted for cardiovascular disease, when selected for 
training and before launch, yet cardiac arrhythmias and symptoms of ischemia have still 
been reported during spaceflight (Marshburn 2008). 
For ISS crews, each ISS member agency selects and certifies their respective 
crewmembers using agreed-upon medical requirements and standards developed by the 
Multilateral Medical Operations Panel. Member agencies then submit their candidates to 
the Multilateral Space Medicine Board (MSMB) for review; the MSMB is responsible for 
the implementation of medical selection and crew certification standards, specifically 
determining eligibility of ISS and visiting crewmembers. Eligibility is determined after 
in-depth clinical review of all medical data for each potential crewmember, and 
multilateral consensus is required for certification. Waivers for conditions that are outside 
of the accepted multilateral standards have been granted in exceptional cases 
(Bogomolov et al. 2009). While each crewmember is on-orbit, his or her health is 
monitored by their respective crew surgeon through weekly private medical conferences 
and periodic health assessments. Status of the crew is discussed each week by 
teleconference with the Space Medicine Operations Team. 
Since the early years of the ISS, perceptions of the cardiovascular disease risk and 
strategies for screening for cardiovascular disease before a spaceflight mission have 
evolved. Identification of “several cases of latent coronary artery disease” prompted the 
reassessment of cardiovascular health screening practices for ISS crews (Bogomolov et 
al. 2009). Consequently, ISS partners added screening elements including the 
Framingham Risk Score, high-sensitivity C-reactive protein levels, and electron beam 
computed tomography or multi-detector coronary angiography. The utility of these tools 
in an apparently healthy population has been demonstrated. For example, elevated 
coronary artery calcium scores are associated with increased risk of coronary heart 
disease, even in asymptomatic men and women (LaMonte et al. 2005). Further, coronary 
calcium scores have been associated with the degree of stenosis; individuals with CAC 
scores of 0 have a very low probability (<1%) of stenosis (Haberl et al. 2001). It is 
expected that adding these elements to the screening will decrease the likelihood that a 
crewmember will experience an acute cardiac event during a mission that would require 
immediate care or de-orbiting of the crew, and these tests also will improve the long-term 
health of the crew. Future screening modalities may provide additional information to 
protect crews during exploration missions (Romero et al. 2015).  For example, it has been 
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established that some arrhythmias, including atrial fibrillation (Lin et al. 2016), and some 
cardiovascular disease risk factors are inherited and could be screened genetically. 
 
E.  On-Orbit Treatment 
Successful treatment of cardiac events that occur during the course of an exploration 
mission will be wholly dependent upon the skill of the crew medical officer and ground 
support, if it is available (Gillis and Hamilton 2012). Currently, ISS crews that do not 
have an assigned physician-astronaut are assigned a designated crew medical officer who 
receives only 30-40 hours of medical training (Gillis and Hamilton 2012). It has not yet 
been decided whether  an astronaut-physician will be assigned to each exploration 
mission. Even if crewmembers are sufficiently trained, some barriers may exist to prevent 
effective diagnosis and treatment of arrhythmias and cardiac events. For example, a 
crewmember may not want to believe that the symptoms that they are experiencing might 
be related to a cardiac event because they may be concerned that the medical diagnosis 
will have a direct and significant impact on the mission (Marshburn 2008). Further, they 
may be more prone to denial because they believe all pre-existing medical conditions or 
risks would have been detected during extensive screenings before and during flight. 
Additionally, Marshburn (Marshburn 2008) has suggested that lower heart rate and blood 
pressure on-orbit (Fritsch-Yelle et al. 1996a) may result in symptoms of cardiac events 
developing only during exertion. The adequacy of physical examination also might be 
affected by background noise in the vehicle (auscultation and ability to hear small 
changes), and by cephalad fluid shift resulting in jugular venous distension (Arbeille et 
al. 2001). Although there likely will be an ultrasound machine onboard exploration 
vehicles to aid in diagnoses, for which the crew would have participated in some 
familiarization training before embarking on a mission, it is still possible that the 
crewmembers will not be well versed in all procedures and thus require remote guidance 
or some form of just-in-time training (Martin et al. 2012). 
On-orbit medical care on the ISS includes cardiac specific medications, 100% oxygen 
supply, and a defibrillator, and presumably similar capabilities will be available for 
exploration missions. On May 15, 1997, the first defibrillator was launched to the Mir 
Space Station, and the Space Shuttle and the ISS were also equipped with defibrillators 
(Marshburn 2008). Cardiopulmonary resuscitation can be performed during 
weightlessness, but this procedure might be less effective than on Earth because the 
rescuer would not benefit from their own body weight during chest compressions, which 
may increase the fatigue rate of first responders. The responder and the patient must be 
restrained during treatment, and the intravenous delivery system must be specialized 
because there would be no assistance of gravity in delivery of fluids and medications.  
 
VI.  CONCLUSIONS 
Although some reports are available, few studies have systematically evaluated the 
prevalence (or potential risk) of cardiac arrhythmias during short- and long-duration 
spaceflight. There are several reports of non life-threatening but potentially concerning 
arrhythmias. Risk factors for arrhythmias, including cardiac atrophy and a prolonged QTc 
interval, have been reported either during or immediately after spaceflight. Recognizing 
the potential severity of the mission impact of a serious arrhythmia or other cardiac event, 
medical screening procedures for astronaut selection and flight assignment have been 
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improved. However, it is unclear at this time whether spaceflight and radiation exposures 
in future exploration missions will contribute to the development of cardiovascular 
diseases that would impact long-term health of astronauts and cosmonauts. 
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IX.  LIST OF ACRONYMS 
 
DCS Decompression sickness 
JSC Johnson Space Center 
NASA National Aeronautics and Space Administration 
ISS International Space Station 
PAC premature atrial contraction 
PVC premature ventricular contraction 
STS Space Transportation System 
VT ventricular tachycardia 
WETF Weightless Environment Training Facility 
 
 
